Charlie Roco

Co-Founder and CTO

Dr. Roco co-founded Parse Biosciences and serves as the company’s Chief Technology Officer. Prior to Parse, he was at the University of Washington where he received several fellowships from the NIH and Fred Hutch Cancer Research Center. This work generated high-profile publications and informed the core technology of Parse Biosciences. Previously, Dr. Roco contributed to innovations in drug delivery and microscopy at the Wyss Institute at Harvard and the University of Pennsylvania. Dr. Roco received a PhD in Bioengineering from the University of Washington and BSE in Biological Systems Engineering from Virginia Tech.

Talks About
#nanoparticles

Preferred Locations
#Northamerica